Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Jan 21.

Published in final edited form as: J Magn Reson Imaging. 2007 Dec;26(6):1618–1625. doi: 10.1002/jmri.21196

Eight mice bearing BT474 tumors of approximately equal size were divided into two groups and treated with 1000 mg/kg gefitinib for two days or control gavage and on the third day the tumor vasculature was studied by lectin-perfusion in vivo staining and by anti-CD31 immunostaining of tumor sections as described in methods. Lectin perfusion staining is in green; anti-CD31 staining is in red.

Eight mice bearing BT474 tumors of approximately equal size were divided into two groups and treated with 1000 mg/kg gefitinib for two days or control gavage and on the third day the tumor vasculature was studied by lectin-perfusion in vivo staining and by anti-CD31 immunostaining of tumor sections as described in methods. Lectin perfusion staining is in green; anti-CD31 staining is in red.